Skip to main content
Signal8

MESA LABORATORIES INC /CO/ (MLAB)

Sector: Industrial Instruments For Measurement, Display, and Control

Industry: Medical - Specialties

Mesa Laboratories, Inc. logo

Mesa Laboratories, Inc.

NASDAQ:MLABTechnology
+7.50%$128.25
CLOSED
AH$128.25+0.00%vs close
Mkt Cap$717.67M
Float5.05M
O/S5.6M
VOL110K sh
$ Vol$13.72M
RVOL1.18×
Inst Own97.8%
Div Yield0.50%
Dilution
Mesa Laboratories, Inc. logoNASDAQ:MLABClosed$128.25+7.50%
Historical Data
DateOpenHighLowCloseVolume
Nov 6, 2026119.47128.60119.47128.25109,672
Nov 5, 2026124.86124.86118.01119.30107,612
Nov 4, 2026128.10131.71126.03126.19110,563
Nov 3, 2026123.82127.44123.74125.4891,471
Nov 2, 2026129.74129.80121.26121.97153,255
Oct 30, 2026132.35132.55127.08127.8173,172
Oct 29, 2026132.98134.38131.65133.0360,916
Oct 28, 2026128.35133.78128.35131.32143,437
Oct 27, 2026130.86133.41128.66129.2590,091
Oct 26, 2026128.87131.19128.87129.8752,472
Oct 23, 2026127.90129.63124.95128.6688,260
Oct 22, 2026129.27131.01127.59129.1077,461
Oct 21, 2026124.21129.78123.76129.2084,176
Oct 20, 2026123.25128.27122.52125.1677,219
Oct 19, 2026123.79125.49122.96123.3175,323
Oct 16, 2026127.96128.14122.23122.4874,353
Oct 15, 2026125.18129.06125.00127.74100,252
Oct 14, 2026125.19129.38125.19126.1679,581
Oct 13, 2026127.76129.69126.80127.56108,693
Oct 12, 2026127.36128.53126.10128.07105,000
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target (median, last 90d)
$110.00-14.2%
Low $110High $110
Ratings Distribution
BUY
3
HOLD
5
SELL
0
TOTAL8
Insider Trades
InsiderTypeShares
Sullivan John James profile photoSullivan John JamesWithholding/Transfer1.2K
Hall Shannon profile photoHall ShannonGrant/Award1.8K
Ladiwala Shiraz Shabanali profile photoLadiwala Shiraz ShabanaliGrant/Award2.5K
Sullivan John James profile photoSullivan John JamesGrant/Award1.8K
Tripeny R Tony profile photoTripeny R TonyGrant/Award1.8K
Capone Mark Christopher profile photoCapone Mark ChristopherGrant/Award2.4K
Shareholders
97.8%
Institutional
(168)
2.8%
Insiderⓘ
(10)
0.0%
5%+ Owners
(0)
-
Unattributed (incl. retail)ⓘ
Institutional97.8%
Insider2.8%
Top Shareholders
NameShares%
Conestoga Capital Advisors logo
Conestoga Capital Advisors
· filed Jan 2025
618.1K11.0%
Long Path Partners LP logo
Long Path Partners LP
477.1K8.5%
Long Path Smaller Companies Fund, LP logo
Long Path Smaller Companies Fund, LP
· also on 13F· joint filing· may incl. warrants· filed Jul 2026
477.1K8.5%
BlackRock, Inc. logo
BlackRock, Inc.
· also on 13F· may incl. warrants· filed Oct 2026
443.7K7.9%
BlackRock, Inc. logo
BlackRock, Inc.
440.6K7.9%
Wasatch Advisors LP logo
Wasatch Advisors LP
· also on 13F· may incl. warrants· filed Oct 2026
387.1K6.9%
WASATCH ADVISORS LP logo
WASATCH ADVISORS LP
387.1K6.9%
ROYCE & ASSOCIATES LP logo
ROYCE & ASSOCIATES LP
· also on 13F· may incl. warrants· filed Apr 2025
271.1K4.8%
Boston Partners logo
Boston Partners
265.1K4.7%
VANGUARD CAPITAL MANAGEMENT LLC logo
VANGUARD CAPITAL MANAGEMENT LLC
237.5K4.2%
Sources: 13F, Form 4, 13D/13GO/S: 5.6M · as of 3 Aug 2026 · SEC cover page
Insiders & Institutional Holders
About

Mesa Laboratories, Inc. (MLAB) operates as a global enterprise focused on the creation, production, and distribution of essential life science tools, quality assurance products, and specialized services.

Its market reach extends across the United States, Europe, the Asia Pacific region, and other international territories.

The company's operations are organized into four distinct segments: 1. Sterilization and Disinfection Control: This division manufactures and supplies biological, chemical, and cleaning indicators designed to verify the effectiveness of sterilization and disinfection protocols. These products are vital for industries such as hospitals, dental practices, medical device manufacturing, and pharmaceuticals.

Additionally, it offers specialized testing and laboratory services, primarily catering to the dental sector. 2. Biopharmaceutical Development: This segment is dedicated to developing, producing, and marketing automated solutions for protein analysis, including immunoassays, and comprehensive peptide synthesis technologies.

Its portfolio encompasses analysis equipment, CDs, kits, and buffers for protein analysis, alongside peptide synthesizers that automate the chemical creation of peptides. These synthesized peptides are utilized in the development of therapeutic agents, biomaterials, cosmetic products, and general scientific research. 3. Calibration Solutions: This division designs, manufactures, and commercializes quality control and calibration instruments. These products are crucial for accurately measuring and calibrating parameters such as temperature, pressure, pH, and humidity, ensuring health and safety standards. Their applications span hospitals, medical device and pharmaceutical manufacturing facilities, and various laboratory and healthcare environments. Key offerings include continuous monitoring systems, dialysate meters and their consumables, data logging devices, gas flow calibration and air sampling equipment, and torque testing systems. 4. Clinical Genomics: This segment innovates, produces, and provides advanced genetic analysis tools. A prominent offering is the MassARRAY system, complemented by essential consumables like chips, panels, and chemical reagent solutions. These tools enable clinical laboratories to perform genomic testing across several therapeutic areas, including newborn screening, pharmacogenomics, and oncology. Mesa Laboratories, Inc. was established in 1982 and is headquartered in Lakewood, Colorado.

Key Metrics
Market Cap$717.67M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership97.77%

based on 5.60M shares outstanding

SectorTechnology
IndustryHardware, Equipment & Parts
ExchangeNASDAQ
CountryUSUS
IPO Date-
Shares Outstanding5.60M
Authorized Shares
Float5.05M
52-Week Range
$69.51$144.35
$128.25(78th percentile)
Volume
Average Daily Volume93.15K
109.67K today vs 93.15K avg(+18%)

30d Avg

93.15K

60d Avg

107.27K

90d Avg

124.57K

Earnings
Dividend History
TTM Yield
0.50%
Paid quarterly
Annual (LTM)
$0.64
Latest
$0.1600
Nov 30, 26
5Y Growth
+0.00%
per year
Compliance Status
Loading compliance data...